PRESS RELEASE published on 02/19/2025 at 08:28, 1 month 22 days ago Inside Information / Other news releases Medincell announces successful c.€43 million Global Offering, strengthening funding for expanding BEPO® technology into new molecules and indications, integrating complementary technologies, improving shareholder structure, and enhancing financial flexibility Pharmaceutical Financial Flexibility Medincell Global Offering BEPO® Technology
BRIEF published on 02/18/2025 at 18:57, 1 month 22 days ago Medincell launches a Global Offer of 10% of its capital Profitability Partnerships Medincell Global Offer BEPO Technology
BRIEF published on 02/18/2025 at 18:57, 1 month 22 days ago Medincell lance une Offre Globale de 10% de son capital Rentabilité Partenariats Medincell Offre Globale Technologie BEPO
PRESS RELEASE published on 02/18/2025 at 18:52, 1 month 22 days ago Inside Information / Other news releases Medincell launches a Global Offering to expand its BEPO technology reach into new molecules and indications. Funds raised will strengthen licensing opportunities and improve shareholder structure Shareholder Structure Licensing Opportunities Medincell Global Offering BEPO Technology
PRESS RELEASE published on 02/18/2025 at 18:52, 1 month 22 days ago Informations privilégiées / Autres communiqués Medincell lance une Offre Globale de 10% de son capital, visant à intensifier les partenariats et créer de la valeur ajoutée. L'offre s'adresse aux investisseurs institutionnels internationaux et aux actionnaires individuels en France Partenariats Investisseurs Valeur Ajoutée Medincell Offre Globale
BRIEF published on 02/06/2025 at 19:35, 2 months 6 days ago EIB Supports Medincell by Waiving Financial Covenants Loan Agreement Credit Facility Medincell Financial Covenants EIB
BRIEF published on 02/06/2025 at 19:35, 2 months 6 days ago La BEI soutient Medincell en renonçant à ses engagements financiers Facilité De Crédit BEI Contrat De Prêt Médinecell Clauses Financières
PRESS RELEASE published on 02/06/2025 at 19:30, 2 months 6 days ago Informations privilégiées / Autres communiqués La BEI lève deux clauses financières du contrat de prêt avec Medincell. 40 millions d'euros accordés en 2022 remplacent un prêt de 20 millions. Tranches A, B, C tirées en 2022-2023, première maturité en 2027. Deux clauses financières seront levées Medincell Maturité BEI Prêt Clauses Financières
PRESS RELEASE published on 02/06/2025 at 19:30, 2 months 6 days ago Inside Information / Other news releases The EIB permanently waives two financial covenants in Medincell's loan agreement, showing confidence. €40M credit facility structure and key details explained Loan Agreement Credit Facility Medincell Financial Covenants EIB
BRIEF published on 01/29/2025 at 15:47, 2 months 14 days ago UZEDY® réalise un chiffre d'affaires de 117 millions de dollars en 2024 Teva Pharmaceuticals Prévisions Pour 2025 Olanzapine Injectable Ventes UZEDY® Partenariat Medincell
Published on 04/12/2025 at 15:45, 23 hours 32 minutes ago New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CFO Julia Qian, BIOVie’s Dr. Joseph Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice Presid
Published on 04/12/2025 at 02:00, 1 day 13 hours ago Battery X Metals Announces Provisional Patent Application with United States Patent & Trademark Office for Lithium-Ion Battery Rebalancing Technology Innovations
Published on 04/12/2025 at 00:10, 1 day 15 hours ago Applied Minerals, Inc. Files Motion to Approve Disclosure Statement
Published on 04/11/2025 at 23:45, 1 day 15 hours ago Gold Terra Closes First Tranche of Financing Package with Support from Osisko Gold Royalties
Published on 04/11/2025 at 21:45, 1 day 17 hours ago OPPO Unveils Agentic AI Initiative at Google Cloud Next 2025, Showcasing Innovations and Leadership in AI Experiences
Published on 04/11/2025 at 18:38, 1 day 20 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/11/2025 at 18:23, 1 day 20 hours ago EQS-Adhoc: Cherry SE: Cherry SE recognizes asset impairment for 2024; updates adjusted EBITDA margin for fiscal year 2024
Published on 04/11/2025 at 18:30, 1 day 20 hours ago Reclassification of shares within the Feuillet family concert with no impact on the control of the company
Published on 04/11/2025 at 18:30, 1 day 20 hours ago Reclassement d'actions au sein du concert familial Feuillet sans incidence sur le contrôle de la société
Published on 04/11/2025 at 18:00, 1 day 21 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/03/2025
Published on 04/11/2025 at 18:00, 1 day 21 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/03/2025
Published on 04/11/2025 at 17:50, 1 day 21 hours ago Mise à disposition du Rapport Financier Annuel 2024